CoChat

Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma

Open access
Zhou, Xinke, Chen, Jitao, Yi, Gao, Deng, Min, Liu, Hao, Liang, Min, Shi, Boyun, Fu, Xin, Chen, Yuqin, Chen, Liangcai, He, Zhimin, Wang, Jian, Liu, Jifang · 2016 · Oncotarget
Cited by 109

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

// Xinke Zhou 1, * , Jitao Chen 1, 2, * , Gao Yi 1, * , Min Deng 2 , Hao Liu 2 , Min Liang 1 , Boyun Shi 1 , Xin Fu 3 , Yuqin Chen 3 , Liangcai Chen 1, 2 , Zhimin He 2 , Jian Wang 3 , Jifang Liu 1, 2 1 Department of Respiratory Medicine and Cancer Center, The 5th Affiliated Hospital of Guangzhou Medical University, Guangzhou, PR China 2 Cancer Hospital and Cancer Research Institute, Guangzhou Medical University, Guangzhou, PR China 3 State Key Laboratory of Respiratory Disease, The 1st Affiliated Hospital of Guangzhou Medical University, Guangzhou, PR China * These authors have contributed equally to this work Correspondence to: Jian Wang, e-mail: jianwang1986@yahoo.com Jifang Liu, e-mail: yzhbb2012@126.com Keywords: HIF-1α, metformin, metabolic reprogramming, hypoxia, hepatocellular carcinoma Received: June 28, 2015 Accepted: November 16, 2015 Published: November 28, 2015 ABSTRACT Overexpression of hypoxia-induced factor 1α (HIF-1α) has been shown to be involved in the development and progression of hepatocellular carcinoma (HCC). HIF-1α should therefore be a promising molecular target for the development of anti-HCC agents. Metformin, an established antidiabetic drug, has proved to also be effective in treating cancer although the precise underlying mechanisms of this activity are not fully elucidated. The aim of this study was to investigate the effects of metformin on the expression of HIF-1α and oxygen metabolism in HCC. The results showed that metformin inhibited hypoxia-induced HIF-1α accumulation and activation independent of AMP-activated protein kinase (AMPK). Moreover, this decrease in HIF-1α accumulation was accompanied by promotion of HIF-1α protein degradation. In addition, metformin significantly decreased oxygen consumption, ultimately leading to increased intracellular oxygen tension and decreased staining with the hypoxia marker pimonidazole. In vivo studies demonstrated that metformin delayed tumor growth and attenuated the expression of HIF-1α in HCC tumor xenografts. Together, these findings suggest that metformin decreases hypoxia-induced HIF-1α accumulation by actively suppressing mitochondrial oxygen consumption and enhancing cellular oxygenation ability, providing a fundamental mechanism of metformin activity against HCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.6418

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

Metadata

Authors
Zhou, X., Chen, J., Yi, G., Deng, M., Liu, H., Liang, M., Shi, B., Fu, X., Chen, Y., Chen, L., He, Z., Wang, J., & Liu, J.
Venue
Oncotarget
Published
2015-11-28
Volume
7
Issue
1
Pages
873-884
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2235653829
Cited by
109
References
12
FWCI
2.45
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.